SPOROS BIOVENTURES
Sporos Bioventures is a biotechnology firm that focuses on oncology, fibrosis, inflammation, and autoimmune and infection therapeutics. For patients with cancer and immune diseases, Sporos is transforming knowledge into a new hope. Sporos' team of accomplished leaders identifies novel disease mechanisms and catalyzes the development of breakthrough medicines by leveraging our extensive network, strategic resources, and operational expertise.
SPOROS BIOVENTURES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Status:
Active
Total Funding:
38.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-15 | Tvardi Therapeutics | Sporos Bioventures investment in Series B - Tvardi Therapeutics | 72.42 M USD |
| 2021-06-03 | Stellanova Therapeutics | Sporos Bioventures investment in Series A - Stellanova Therapeutics | 15.5 M USD |
| 2021-05-25 | Asylia Therapeutics | Sporos Bioventures investment in Series A - Asylia Therapeutics | 14.5 M USD |
| 2021-01-26 | Nirogy Therapeutics | Sporos Bioventures investment in Series A - Nirogy Therapeutics | 16.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-29 | Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer |